Although obesity is now recognized as an increasingly important cause of cancer in the United States and worldwide, no medications have been proven to lower the cancer risk associated with obesity, said lead investigator Lucas Mavromatis, ScB, a medical student at the New York University Grossman School of Medicine, in an ASCO news release
Expression of glucose transporters in duodenal mucosa of patients with type 1 diabetes
New results from the Regeneron Phase 2 COURAGE trial, led by Julio Rosenstock, MD, at Velocitys site in Dallas, TX, point to a potential solution
an in-person doctor and an FDA-approved finished product offer different assurances and often higher cost
doi: 10.1038/s41467-022-27975-9 68 SakaiK.NakazatoY.ShiimuraY.ZhangW.NakazatoM